DR AGARWALS HEALTH CARE L (AGARWALEYE) financials

DR AGARWALS HEALTH CARE L (AGARWALEYE) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2010,[1]Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care.[2]

Market Cap: ₹15,065Cr.
Current Price: ₹475
Stock P/E: 309
ROE: 1.67%
ROCE: 5.31%
Book Value: ₹62.9
Dividend Yield: 0.00%
52W High / Low: ₹568/401

In Jun 2026, DR AGARWALS HEALTH CARE L (AGARWALEYE) reported sales ₹383 Cr and net profit ₹17 Cr.

Annual TTM: sales ₹1,374 Cr, net profit ₹46 Cr.

Shareholding: Promoters 32.33% (Sep 2026), FIIs 49.56% (Sep 2026), DIIs 15.86% (Sep 2026), Public 2.23% (Sep 2026), No. of Shareholders 42,055% (Sep 2026).

AGARWALEYE quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	255	268	281	302	309	335	348	383
Expenses	198	203	208	235	240	255	256	287
Operating Profit	58	65	73	67	69	80	92	96
OPM %	23%	24%	26%	22%	22%	24%	26%	25%
Other Income	5	10	24	12	6	6	1	3
Interest	23	23	21	19	17	18	19	19
Depreciation	38	39	42	44	48	48	56	58
Profit before tax	1	12	34	16	10	20	18	22
Tax %	746%	37%	22%	35%	51%	31%	42%	26%
Net Profit	-4	8	27	10	5	14	11	17
EPS in Rs	—	0.25	0.84	0.32	0.15	0.44	0.33	0.53
Raw PDF	—	—	—	—	—	—	—	—

AGARWALEYE profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	248	232	362	598	835	1,044	1,293	1,374
Expenses	202	199	275	436	611	795	981	1,038
Operating Profit	46	33	86	162	224	249	312	336
OPM %	19%	14%	24%	27%	27%	24%	24%	24%
Other Income	9	4	10	-12	38	40	26	17
Interest	42	34	38	64	88	94	77	73
Depreciation	49	55	59	92	129	156	197	210
Profit before tax	-36	-52	-1	-6	45	39	64	71
Tax %	0%	4%	55%	-641%	47%	43%	38%	—
Net Profit	-36	-54	-1	32	24	22	39	46
EPS in Rs	—	—	—	—	—	0.69	1.25	1.45
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

AGARWALEYE balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	7	7	7	7	8	9	32	32
Reserves	290	248	194	192	554	1,218	1,902	1,960
Borrowings	135	142	161	252	590	661	568	670
Other Liabilities	60	200	281	242	236	298	335	300
Total Liabilities	492	596	643	692	1,388	2,187	2,837	2,961
Fixed Assets	99	322	387	367	907	1,302	1,591	1,922
CWIP	1	3	11	2	35	9	18	29
Investments	238	146	121	147	187	629	729	615
Other Assets	154	124	124	176	258	248	498	395
Total Assets	492	596	643	692	1,388	2,187	2,837	2,961

AGARWALEYE cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	—	40	46	78	153	222	206	321
Cash from Investing Activity	—	-37	-26	-98	-436	-818	-577	-167
Cash from Financing Activity	—	-60	-21	40	316	570	374	-173
Net Cash Flow	—	-56	-1	20	33	-26	2	-19
Free Cash Flow	—	-91	23	12	76	87	15	6
CFO/OP	—	94%	147%	94%	102%	105%	80%	113%

AGARWALEYE shareholding pattern (%)
Category	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	32.45%	32.43%	32.43%	32.39%	32.35%	32.34%	32.33%
FIIs	60.62%	59.26%	58.13%	58.06%	57.94%	57.97%	49.56%
DIIs	5.21%	6.44%	7.92%	7.78%	7.83%	7.72%	15.86%
Public	1.74%	1.87%	1.52%	1.78%	1.87%	1.97%	2.23%
No. of Shareholders	68,696	63,021	48,168	46,554	43,538	42,492	42,055

AGARWALEYE key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	46	46	39	31	24	22	25	23
Inventory Days	138	159	147	149	119	135	69	66
Days Payable	330	427	608	456	354	383	118	122
Cash Conversion Cycle	-147	-222	-422	-276	-210	-226	-24	-32
Working Capital Days	5	-37	-43	-54	-88	-79	-54	-38
ROCE %	—	1%	-5%	9%	10%	8%	6%	5%

AGARWALEYEUpdated 13 Oct 2026, 5:03

Dr Agarwals Health Care L

AGARWALEYEUpdated 13 Oct 2026, 5:03

Market Cap

₹15,065Cr.

Current Price

₹475

High / Low

₹568/401

Stock P/E

309

ROE1.67%

ROCE5.31%

Book Value₹62.9

Face Value₹1.00

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Dec 2023	213	22	158	13	32	15	37	10	—
Mar 2024	225	22	157	13	35	24	29	17	—
Jun 2024	240	23	190	2	37	-8	5	-9	—
Sep 2024	255	23	198	5	38	1	746	-4	—
Dec 2024	268	23	203	10	39	12	37	8	0.25
Mar 2025	281	21	208	24	42	34	22	27	0.84
Jun 2025	302	19	235	12	44	16	35	10	0.32
Sep 2025	309	17	240	6	48	10	51	5	0.15
Dec 2025	335	18	255	6	48	20	31	14	0.44
Mar 2026	348	19	256	1	56	18	42	11	0.33
Jun 2026	383	19	287	3	58	22	26	17	0.53

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2019	202	20	186	5	21	-20	0	-20	—
Mar 2020	248	42	202	9	49	-36	0	-36	—
Mar 2021	232	34	199	4	55	-52	4	-54	—
Mar 2022	362	38	275	10	59	-1	55	-1	—
Mar 2023	598	64	436	-12	92	-6	-641	32	—
Mar 2024	835	88	611	38	129	45	47	24	—
Mar 2025	1044	94	795	40	156	39	43	22	0.69
Mar 2026	1293	77	981	26	197	64	38	39	1.25
TTM	1374	73	1038	17	210	71	—	46	1.45

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	32.33%
FIIs	49.56%
DIIs	15.86%
Public	2.23%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Mar 2025	32.45%	60.62%	5.21%	1.74%
Jun 2025	32.43%	59.26%	6.44%	1.87%
Sep 2025	32.43%	58.13%	7.92%	1.52%
Dec 2025	32.39%	58.06%	7.78%	1.78%
Mar 2026	32.35%	57.94%	7.83%	1.87%
Jun 2026	32.34%	57.97%	7.72%	1.97%
Sep 2026	32.33%	49.56%	15.86%	2.23%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2019	7	290	135	60	492	99	1	238	154	492
Mar 2020	7	248	142	200	596	322	3	146	124	596
Mar 2021	7	194	161	281	643	387	11	121	124	643
Mar 2022	7	192	252	242	692	367	2	147	176	692
Mar 2023	8	554	590	236	1388	907	35	187	258	1388
Mar 2024	9	1218	661	298	2187	1302	9	629	248	2187
Mar 2025	32	1902	568	335	2837	1591	18	729	498	2837
Mar 2026	32	1960	670	300	2961	1922	29	615	395	2961

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2019	—	—	—	—
Mar 2020	40	-37	-60	-56
Mar 2021	46	-26	-21	-1
Mar 2022	78	-98	40	20
Mar 2023	153	-436	316	33
Mar 2024	222	-818	570	-26
Mar 2025	206	-577	374	2
Mar 2026	321	-167	-173	-19

Key ratios

Historical financial ratios

Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	46	46	39	31	24	22	25	23
Inventory Days	138	159	147	149	119	135	69	66
Days Payable	330	427	608	456	354	383	118	122
Cash Conversion Cycle	-147	-222	-422	-276	-210	-226	-24	-32
Working Capital Days	5	-37	-43	-54	-88	-79	-54	-38
ROCE %	—	1%	-5%	9%	10%	8%	6%	5%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of DR AGARWALS HEALTH CARE L (AGARWALEYE)?

The reported market capitalisation for DR AGARWALS HEALTH CARE L (AGARWALEYE) is ₹15,065Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of AGARWALEYE?

The current price shown for DR AGARWALS HEALTH CARE L (AGARWALEYE) on Fincrux is ₹475 with a 52-week high/low of ₹568/401.

What is the P/E ratio of DR AGARWALS HEALTH CARE L (AGARWALEYE)?

The stock P/E for DR AGARWALS HEALTH CARE L (AGARWALEYE) is 309 on Fincrux, with ROE at 1.67% and ROCE at 5.31%.

What were AGARWALEYE latest quarterly results?

For Jun 2026, DR AGARWALS HEALTH CARE L (AGARWALEYE) reported sales ₹383 Cr and net profit ₹17 Cr (figures in ₹ crore unless noted).

What are AGARWALEYE annual sales and net profit?

For TTM, DR AGARWALS HEALTH CARE L (AGARWALEYE) shows sales of ₹1,374 Cr and net profit of ₹46 Cr on the Fincrux profit & loss statement.

Who owns DR AGARWALS HEALTH CARE L (AGARWALEYE)?

Latest shareholding for DR AGARWALS HEALTH CARE L (AGARWALEYE) on Fincrux: Promoters 32.33% (Sep 2026), FIIs 49.56% (Sep 2026), DIIs 15.86% (Sep 2026), Public 2.23% (Sep 2026), No. of Shareholders 42,055% (Sep 2026).

Where can I find DR AGARWALS HEALTH CARE L (AGARWALEYE) financials?

DR AGARWALS HEALTH CARE L (AGARWALEYE) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show AGARWALEYE balance sheet and cash flow?

Yes. The DR AGARWALS HEALTH CARE L (AGARWALEYE) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 5:03